Mortality in patients with giant cell arteritis in Spain: results from the ARTESER registry

Further Publications Rheumatology

Cerebrovascular accidents in giant cell arteritis: prevalence and predictive factors from the ARTESER registry

Rheumatology (Oxford)

Martín-Gutiérrez A, Molina-Collada J, Domínguez-Álvaro M, Melero-González RB, Fernández-Fernández E, Silva-Díaz M, Valero JA, González I, Martín JS, Narváez J, Calvo I, Aldasoro V, Abasolo Alcázar L, Loricera J, Ruíz-Roman A, Castañeda S, Molina-Almela C, Alcalde Villar M, Juan Mas A, Blanco R, ARTESER Project Collaborative Group

doi: 10.1093/rheumatology/keaf051

Further Publications Rheumatology

The giant cell arteritis (GCA) ultrasound score (OGUS) at diagnosis and after initial treatment predicts future relapses in GCA patients: results of a multicentre prospective study

Ann Rheum Dis

Monti S, Ponte C, Schäfer VS, Rozza D, Scirè C, Franchi G, Milanesi A, Khmelinskii N, Petzinna SM, Carrara G, Di Nicola C, Fonseca JE, Montecucco C, Schmidt WA, Dejaco C, Luqmani RA

doi: 10.1016/j.ard.2025.01.018

Further Publications Immunology

Predictors of Mortality in Antiphospholipid Antibody Positive Patients: Prospective Results from Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository ("Registry")

Arthritis Care Res (Hoboken)

Ahmadzadeh Y, Magder LS, de Andrade DCO, Paredes-Ruiz D, Tektonidou MG, Pengo V, Sciascia S, Andreoli L, Signorelli F, Fortin PR, Efthymiou M, Belmont HM, Barilaro G, Clarke AE, Atsumi T, López-Pedrera C, Knight JS, Branch DW, Willis R, Kello N, Zhang Z, Rodriguez Almaraz E, Artim-Esen B, Pardos-Gea J, Pons-Estel G, Pazzola G, Shi H, Duarte-García A, Thaler J, Barber MRW, Skeith L, Radin M, Meroni PL, Roubey R, Bertolaccini ML, Cohen H, Petri M, Erkan D

doi: 10.1002/acr.25503

Further Publications Rheumatology

Tocilizumab in cranial and extracranial giant cell arteritis: a national multicenter study of 471 cases

Rheumatology (Oxford)

Blanco R, Aldasoro V, Maiz O, Melero R, Romero-Yuste S, de Miguel E, Ferraz-Amaro I, López-Gutiérrez F, Castañeda S, Loricera J, Tocilizumab in Giant Cell Arteritis Spanish Collaborative Group

doi: 10.1093/rheumatology/keae666

Atopic Dermatitis

Dupilumab provides sustained effectiveness on patient-reported outcomes and favorable safety in patients with moderate-to-severe atopic dermatitis: up to 5-year results from the daily practice BioDay Registry

J Am Acad Dermatol

Zhang J, Boesjes CM, Loman L, Kamphuis E, Romeijn MLE, Spekhorst LS, Haeck I, van der Gang LF, Dekkers CC, van der Rijst LP, Oosting AJ, van Lumig P, van Lynden-van Nes AMT, Tupker RA, Nijssen A, Flinterman A, Politiek K, Touwslager WRH, Christoffers WA, Stewart SM, Kamsteeg M, de Graaf M, de Bruin-Weller MS, Schuttelaar MA

doi: 10.1016/j.jaad.2024.04.026

Further Publications Immunology

Impact of exposure to environmental particulate matter on the onset of giant cell arteritis

Arthritis Care Res (Hoboken)

Bond M, Tomelleri A, Reatini MA, Campochiaro C, Cattani G, Dagna L, Rossini M, Dejaco C, Adami G

doi: 10.1002/acr.25404

Further Publications Rheumatology

Compression ratio: a novel method to quantify compressibility as a diagnostic measurement in giant cell arteritis

Rheumatology (Oxford)

Khurshid MA, Mynors-Wallis D, Richards S, Barclay C, Fox C, Budka M, Hopkinson N, Young-Min S

doi: 10.1093/rheumatology/keae674

Further Publications Rheumatology

Polymyalgia rheumatica is a risk factor for more recalcitrant disease in giant cell arteritis: A retrospective cohort study

Semin Arthritis Rheum

Moreel L, Betrains A, Boeckxstaens L, Molenberghs G, Van Laere K, De Langhe E, Vanderschueren S, Blockmans D

doi: 10.1016/j.semarthrit.2024.152499

Further Publications Dermatology

Mohs micrographic surgery in immunosuppressed vs immunocompetent patients: Results of a prospective nationwide cohort study (REGESMOHS, Spanish registry of Mohs surgery)

J Eur Acad Dermatol Venereol

Abril-Pérez C, Mansilla-Polo M, Escutia-Muñoz B, Sanmartín O, Garcés JR, Rodríguez-Prieto MA, Ruiz-Salas V, de Eusebio-Murillo E, Miñano-Medrano R, González-Sixto B, Artola-Igarza JL, Alfaro-Rubio A, Redondo P, Delgado-Jiménez Y, Sánchez-Schmidt JM, Allende-Markixana I, Alonso-Pacheco ML, García-Bracamonte B, de la Cueva-Dobao P, Navarro-Tejedor R, Ciudad-Blanco C, Carnero-González L, Vázquez-Veiga H, Cano-Martínez N, Serra-Guillén C, Vilarrasa E, Sánchez-Sambucety P, López-Estebaranz JL, Flórez-Menéndez Á, Martorell-Calatayud A, Gil P, Morales-Gordillo V, Toll A, Ocerin-Guerra I, Mayor-Arenal M, Suárez-Fernández R, Sainz-Gaspar L, Descalzo MA, Garcia-Doval I, Botella-Estrada R, REGESMOHS (Registro Español de Cirugía de Mohs)

doi: 10.1111/jdv.20103

Related content

Cerebrovascular accidents in giant cell arteritis: prevalence and predictive factors from the ARTESER registry

The giant cell arteritis (GCA) ultrasound score (OGUS) at diagnosis and after initial treatment predicts future relapses in GCA patients: results of a multicentre prospective study

Predictors of Mortality in Antiphospholipid Antibody Positive Patients: Prospective Results from Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository ("Registry")

Tocilizumab in cranial and extracranial giant cell arteritis: a national multicenter study of 471 cases

Dupilumab provides sustained effectiveness on patient-reported outcomes and favorable safety in patients with moderate-to-severe atopic dermatitis: up to 5-year results from the daily practice BioDay Registry

Impact of exposure to environmental particulate matter on the onset of giant cell arteritis

Compression ratio: a novel method to quantify compressibility as a diagnostic measurement in giant cell arteritis

Polymyalgia rheumatica is a risk factor for more recalcitrant disease in giant cell arteritis: A retrospective cohort study

Mohs micrographic surgery in immunosuppressed vs immunocompetent patients: Results of a prospective nationwide cohort study (REGESMOHS, Spanish registry of Mohs surgery)